All research papers
2996 approved papers, newest first · showing 121–180.Search instead →
- 8 Oct 2026· The Journal of urology· Ga-68 PSMA PET· DiagnosticDiagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography / Magnetic Resonance Imaging in Selected Men with Equivocal Prostate Imaging Reporting and Data System Category 3 Lesion (PANDORA): A Prospective Paired Diagnostic Study.Diamand R et al.
- 8 Oct 2026· Endocrine-related cancer· Lu-177 DOTATATE· TherapeuticApplying 177Lu-Dotatate for Hereditary Neuroendocrine Tumours: The Role in MEN1.Becx MN et al.
- 7 Oct 2026· Frontiers in oncology· SBRT delivery· Therapeutic· Free full textLASSO-based nomogram to predict early treatment failure in advanced hepatocellular carcinoma treated with SBRT, lenvatinib, and tislelizumab.Zhao Y et al.
- 7 Oct 2026· Frontiers in oncology· MR-linac / MR-guided· Therapeutic· Free full textA prospective pilot study of urine microRNA as a biomarker of urinary radiation toxicity following MRI-guided prostate stereotactic body radiotherapy.Smyczyńska U et al.
- 7 Oct 2026· Clinical and translational radiation oncology· Adaptive radiotherapy· TherapeuticFeasibility and potential benefits of daily online adaptive radiotherapy for head and neck cancer without margin reduction using an RTT-only workflow.Lindegaard AM et al.
- 7 Oct 2026· Journal of neuro-oncology· SRS / intracranial· TherapeuticVolumetric analysis of radiographic changes after stereotactic radiosurgery for treatment of non-responding brain metastases.Rajkumar S et al.
- 7 Oct 2026· Journal of medical imaging and radiation oncology· SBRT delivery· TherapeuticLinear Accelerator-Based Stereotactic Body Radiotherapy of 36.25 Gy in Five Fractions for Localised Prostate Cancer: A Retrospective Single-Institution Cohort Study.Katano A et al.
- 7 Oct 2026· Journal of clinical oncology· SBRT delivery· TherapeuticNRG-BR002: A Randomized Phase II/III Trial of Metastasis-Directed Ablation With First-Line Systemic Therapy for Oligometastatic Breast Cancer.Chmura SJ et al.
- 7 Oct 2026· ACS applied bio materials· Ra-223· Therapeutic'All-in-One' Micro- and Nanoscale MOFs for Combined Chemo-Radionuclide Therapy of Breast Cancer.Akhmetova D et al.
- 7 Oct 2026· The quarterly journal of nuclear medicine and molecular imaging· Lu-177 FAPI· DiagnosticThe added value of [68Ga]Ga-FAPI-46 PET/CT imaging in oncology: a real-world clinical setting.VAN DEN Bos M et al.
- 7 Oct 2026· Abdominal radiology (New York)· Lu-177 FAPI· DiagnosticDiagnostic performance of [<sup>18</sup>F]-FDG or [<sup>68</sup>Ga]-FAPI PET/MRI for nodal assessment in colorectal cancer: a retrospective comparative analysis.Zhao M et al.
- 7 Oct 2026· European radiology· Lu-177 FAPI· DiagnosticPreoperative [<sup>18</sup>F]FAPI-42 PET/CT is associated with tumor budding in colorectal cancer: a dual-center retrospective study.Mu X et al.
- 7 Oct 2026· International journal of molecular sciences· Lu-177 FAPI· DiagnosticTracking Active Fibroblast-Mediated Tissue Remodelling in Cardiomyopathies: Translational Insights from FAPI PET Imaging.Fortuna I et al.
- 6 Oct 2026· Technical innovations & patient support in radiation oncology· Adaptive radiotherapy· TherapeuticAn in-house timer for ART-specific extra time in gynecologic pelvic online adaptive radiation therapy.Zheng Y et al.
- 6 Oct 2026· Practical radiation oncology· In-vivo dosimetry· QA & dosimetryMedical Physicist-Patient Consultation Enhances the Reproducibility of Treatment Delivery in Radiation Therapy for Breast Cancer: An EPID-Based In Vivo Transit Dosimetry Study.Marino C et al.
- 6 Oct 2026· Radiation and environmental biophysics· Patient-specific QA· QA & dosimetryCharacterization of high-resolution detector response for stereotactic patient-specific QA across different TPS-linac systems.Sahin S et al.
- 6 Oct 2026· Nuclear medicine communications· Ac-225 alpha therapy· TherapeuticPublication trends and knowledge structure of prostate-specific membrane antigen radioligand therapy for prostate cancer: a bibliometric analysis, 2015-2025.Long H et al.
- 6 Oct 2026· BMJ open· SBRT delivery· TherapeuticMetastasis-directed radiotherapy (MDRT) for men with de novo, oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial (METANOVA): protocol for a multicentre, phase II randomised controlled trial in the USA.Lichtman-Mikol S et al.
- 5 Oct 2026· Neuroradiology· SRS / intracranial· TherapeuticMultifocal intracranial epstein-barr virus-associated smooth muscle tumors in an HIV-positive patient: incidental discovery and treatment with staged gamma knife radiosurgery.Sutanto R et al.
- 5 Oct 2026· Journal of neuro-oncology· SRS / intracranial· TherapeuticDose selection and clinical decision-making after Gamma Knife surgery for large brain metastases: implications for early identification of true progression.Koketsu Y et al.
- 5 Oct 2026· Clinical spine surgery· SBRT delivery· TherapeuticRadiotherapy Advances for Cervical Spine Tumors: Conventional Versus Stereotactic Body Radiotherapy (SBRT).Lilly DT et al.
- 5 Oct 2026· Journal of medical imaging and radiation oncology· SBRT delivery· TherapeuticStereotactic Ablative Body Radiotherapy Versus Microwave Ablation for the Treatment of Early-Stage Hepatocellular Carcinoma.Egan D et al.
- 5 Oct 2026· Physics in medicine and biology· SBRT delivery· TherapeuticIntroduce 4π dynamic spot-scanning proton arc therapy (SPArc-4π) for pancreatic cancer: a comparative planning study with IMPT.Chen P et al.
- 5 Oct 2026· European urology open science· SBRT delivery· TherapeuticOligoprogressive Renal Cell Carcinoma Treated with Stereotactic Body Radiation Therapy Versus Switching to a New Systemic Therapy.Franzese C et al.
- 5 Oct 2026· Applied radiation and isotopes· TLD dosimetry· QA & dosimetryValidation of a 3D-printed anthropomorphic eye phantom for quality assurance in external beam radiotherapy using TLD and radiochromic film.Fidelis ALE et al.
- 5 Oct 2026· Nuklearmedizin. Nuclear medicine· I-131 therapy· TherapeuticMarinelli Equation vs. DIN 6861-1: Comparison of the Achieved Therapeutic Thyroid Dose after Radioiodine Therapy Using Different Pretherapeutic Dosimetry.Heilfort P et al.
- 5 Oct 2026· The international journal of cardiovascular imaging· Lu-177 FAPI· DiagnosticMolecular phenotyping of atrial remodeling in atrial fibrillation using <sup>18</sup>F-FDG and <sup>18</sup>F-FAPI PET.Duan SD et al.
- 5 Oct 2026· JCEM case reports· Lu-177 DOTATATE· Therapeutic· Free full textA case of metastasectomy following multiple courses of radionuclide therapy for distant metastatic pheochromocytoma.Wada N et al.
- 4 Oct 2026· Radiotherapy and oncology· Adaptive radiotherapy· TherapeuticEarly target volume dynamics during MR-guided radiotherapy for glioblastoma: first results from the prospective MARGA-I trial.Kretzschmar L et al.
- 4 Oct 2026· Advanced healthcare materials· Radiopharmaceutical QC· Diagnostic· RadiopharmacySynthesis, Preclinical Evaluation, and Clinical Application of the FAPI-Dimer Based on the LARM Platform.Jia F et al.
- 3 Oct 2026· Annals of biomedical engineering· Adaptive radiotherapy· QA & dosimetryEvaluating Image Quality of Cone Beam Computed Tomography Using HyperSight® on the Varian TrueBeam.Lohela J et al.
- 3 Oct 2026· Japanese journal of radiology· SBRT delivery· TherapeuticLong-term results of stereotactic body radiotherapy boost in patients with cervical cancer considered unsuitable for intracavitary brachytherapy.Ito K et al.
- 3 Oct 2026· Annals of nuclear medicine· I-131 therapy· TherapeuticDose-activity relationship in [<sup>131</sup>I]NaI therapy for differentiated thyroid carcinoma.Luján-Expósito Á.
- 3 Oct 2026· Annals of nuclear medicine· Ga-68 PSMA PET· DiagnosticReconstruction robustness of liver-referenced adaptive thresholding for <sup>68</sup>Ga-PSMA-11 PET/CT volumetry: a comparative analysis of systematic bias and individual-patient variability.Schötz E et al.
- 3 Oct 2026· Japanese journal of radiology· Ga-68 PSMA PET· DiagnosticDiagnostic accuracy of <sup>18</sup>F-PSMA-1007 PET/CT and bone scintigraphy for detecting bone metastases in prostate cancer.Kitajima K et al.
- 3 Oct 2026· European urology· Ga-68 PSMA PET· DiagnosticPSMA-PET/CT-guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT): 5-yr Analysis of a Phase 2 Randomized Controlled Trial.Belliveau C et al.
- 2 Oct 2026· Frontiers in oncology· Adaptive radiotherapy· TherapeuticCBCT-based adaptive radiotherapy and automated radiotherapy decision-making systems: development and current status.Wang S et al.
- 2 Oct 2026· Frontiers in endocrinology· I-131 therapy· TherapeuticAn explainable and leakage-aware machine learning model for early risk stratification of radioiodine-refractory differentiated thyroid cancer: development and single-center geographic external validation.Tan G et al.
- 2 Oct 2026· Frontiers in oncology· Ga-68 PSMA PET· TheranosticComparative analysis of treatment response to PSMA radioligand therapy using Ga-68 PSMA-11 and F-18 DCFPyL PET imaging.Hong CM et al.
- 2 Oct 2026· Biomedical physics & engineering express· Adaptive radiotherapy· TherapeuticExternal evaluation of a deep learning-based algorithm for automated lung tumor and esophagus segmentation on CBCT.Zhang Z et al.
- 1 Oct 2026· Nuclear medicine and biology· Radiopharmaceutical QC· RadiopharmacyProduction of no-carrier-added theranostic Au-199: A systematic evaluation of liquid-liquid extraction from dissolved neutron-irradiated platinum targets.Pressler M et al.
- 1 Oct 2026· Clinical oncology (Royal College of Radiologists (Great Britain))· Breast / lung positioning· TherapeuticRespiratory Instability-driven Cardiac Dose Deviation in Postmastectomy Deep Inspiration Breath-hold Volumetric Modulated Arc Therapy (DIBH VMAT): Development and External Validation of a Respiratory-informed Predictive Framework.Singh S et al.
- 1 Oct 2026· Cancer medicine· I-131 therapy· Therapeutic· Free full textApparent Survival Benefit of Postoperative Radioactive Iodine in Lymph Node-Positive Papillary Thyroid Carcinoma: A Negative-Control Analysis for Unmeasured Confounding.Liu T et al.
- 1 Oct 2026· Molecular pharmaceutics· Ac-225 alpha therapy· Theranostic134Ce/134La Radiotheranostics from PET Surrogation of 225Ac to Auger and Conversion-Electron Therapy.Brejeon A et al.
- 1 Oct 2026· Molecular pharmaceutics· Ac-225 alpha therapy· TherapeuticPreclinical Evaluation of [225Ac]Ac-NM600 Therapeutic Potential for Localized and Metastatic Triple-Negative Breast Cancer.Medina Guevara Y et al.
- 1 Oct 2026· Journal of medicinal chemistry· Ac-225 alpha therapy· TherapeuticDevelopment of Novel 211At-Labeled Agent for Neurotensin Receptor 1-Targeted α-Particle Therapy.Otsu M et al.
- 1 Oct 2026· Molecular pharmaceutics· Lu-177 FAPI· TherapeuticNovel Covalent FAP-Targeted Radiotherapy Drug Based on DOTA-FAP-2286 for Enhanced Tumor Uptake, Retention, and Therapeutic Efficacy.Tang S et al.
- 1 Oct 2026· Journal of medicinal chemistry· Lu-177 FAPI· Diagnostic· RadiopharmacySpirocyclic Reconfiguration of the Piperazine Linker Improves Quinoline-Based FAPI PET Tracer Performance.Wu W et al.
- 1 Oct 2026· Journal of medicinal chemistry· Lu-177 FAPI· Diagnostic· Radiopharmacy[18F]FPyQCP: A Robust FAP-Targeted PET Tracer Integrating Covalent C-18F Labeling and Radiometal Chelation for Enhanced In Vivo Performance.Banerjee SR et al.
- 1 Oct 2026· Journal of neuroendocrinology· Ga-68 DOTATATE· TheranosticNeuropeptides and their receptors in CNS cancer imaging/theranostics: Review of recent advances and increased interest with emphasis on the somatostatin/bombesin/substance P peptide receptor families.Moody TW et al.
- 1 Oct 2026· Journal of applied clinical medical physics· Radiation safety· Free full textDevelopment and validation of a pregnant phantom with adjustable fetal presentation for region-specific fetal radiation dose assessment during pelvic radiography.Matsunaga Y et al.
- 1 Oct 2026· Journal of radiation research· Gold-anchor fiducial markers· Therapeutic· Free full textImage-guided moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.Iizumi T et al.
- 1 Oct 2026· Journal of biomedical physics & engineering· TLD dosimetry· QA & dosimetryComparison of the Measurement Uncertainty of Thermoluminescence Dosimeters (TLD-100 and GR-200) in Clinical Radiotherapy Energies.Sadeghi B et al.
- 1 Oct 2026· Journal of applied clinical medical physics· Adaptive radiotherapy· QA & dosimetryRetrospective log-based quality assurance of real-time MLC adaptation on a helical tomotherapy platform.Crowe SB et al.
- 1 Oct 2026· Journal of applied clinical medical physics· Adaptive radiotherapy· TherapeuticFrequency Schrödinger bridge diffusion model for fast MRI reconstruction in abdominal MR-guided online adaptive radiotherapy.Wang Z et al.
- 1 Oct 2026· Medical physics· MR-linac / MR-guided· DiagnosticSimultaneous T1, T2, R2*, PDFF, and triglyceride quantification in the head and neck using magnetic resonance fingerprinting on a 1.5T MR-Linac.McCullum L et al.
- 1 Oct 2026· Journal of applied clinical medical physics· SRS / intracranial· TherapeuticLongitudinal trends in Gamma Knife radiosurgery utilization across multiple technological generations: A Single-Institution Observational Study.El Basha D et al.
- 1 Oct 2026· BMJ open· SBRT delivery· Therapeutic· Free full textEfficacy and safety of narlumosbart in combination with stereotactic body radiation therapy followed by first-line chemotherapy combined with immunotherapy in advanced driver gene-negative non-small cell lung cancer patients with bone metastases: a phase II, single-arm, single-centre clinical trial protocol.Li J et al.
- 1 Oct 2026· Journal of applied clinical medical physics· Adaptive radiotherapy· Therapeutic· Free full textEvaluation of online dose-guided adaptive fractionation for intact prostate radiotherapy.Gevorkyan GS et al.
- 1 Oct 2026· Clinical and translational radiation oncology· SBRT delivery· Therapeutic· Free full textEfficacy and safety of single-fraction stereotactic body radiotherapy (SBRT) for the curative treatment of extracranial primary Tumors: A collaborative systematic review on behalf of the SBRT Focus Group of the European Society for Radiotherapy & Oncology (ESTRO).Cuccia F et al.